fda tirzepatide decision approves new weight-loss drug Zepbound (tirzepatide) FDA's GLP-1 decision kicks off

We found that participants with higher BMI at baseline were more likely to be female, had more volume overload and greater HF symptom severity, and had more severe systemic inflammation at the time of enrollment

Recently, our company's independently developed, fully synthetic semaglutide active pharmaceutical ingredient (DMF No.: 039932) has successfully completed the U.S

These could signal thyroid changes or indicate that your dose needs adjustment

Humana and Monogram Health are expanding their in-home kidney care program for Medicare Advantage members into Georgia, now comprising 5 states across the southeast